US Tariffs And The EU’s Critical Medicines Act: Lessons On Nearshoring And CMO Diversification

Companies can prepare for measures in different markets that encourage domestic production by evaluating their manufacturing strategies. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Compliance

More from United States